• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型糖尿病患儿的一氧化碳弥散能力

Diffusing capacity for carbon monoxide in children with type 1 diabetes.

作者信息

Villa M P, Montesano M, Barreto M, Pagani J, Stegagno M, Multari G, Ronchetti R

机构信息

Department of Paediatrics, Sant'Andrea Hospital, II Faculty of Medicine, University La Sapienza, Via di Grottarossa, 1035-1039, 00189 Rome, Italy.

出版信息

Diabetologia. 2004 Nov;47(11):1931-5. doi: 10.1007/s00125-004-1548-7. Epub 2004 Nov 24.

DOI:10.1007/s00125-004-1548-7
PMID:15565372
Abstract

AIMS/HYPOTHESIS: Few data are available on lung dysfunction in children with diabetes. We studied the association of pulmonary function variables (flows, volumes and alveolar capillary diffusion) with disease-related variables in children with type 1 diabetes mellitus.

METHODS

We studied 39 children with type 1 diabetes (mean age 10.9+/-2.6 years, disease duration 3.6+/-2.4 years, insulin.kg(-1).day(-1) 0.77+/-0.31) and 30 healthy control children (mean age 10.4+/-3.0 years). Pulmonary function tests included spirometry, N(2) wash-out and the single-breath diffusing capacity for carbon monoxide (DL(CO)) corrected for the alveolar volume (DL(CO)/V(A)). Glycaemic control was assessed on the basis of HbA(1)c, with HbA(1)c values of 8% or less considered to indicate good glycaemic control, and HbA(1)c values of 8% or more considered to indicate poor control.

RESULTS

Children with poor glycaemic control had comparable percentage values for predicted flows and volumes but lower DL(CO)/V(A) values than children with good glycaemic control and healthy control children (86.7+/-12.6 vs 99.8+/-18.4 and 102.0+/-15.7; p<0.05). The predicted DL(CO)/V(A) percentages correlated with HbA(1)c levels (r=-0.39, p=0.013). A multiple regression analysis (stepwise model) controlling for HbA(1)c levels and other disease-related variables (age of disease onset, disease duration, daily insulin dose/kg, sex) identified HbA(1)c levels as the sole predictor of DL(CO)/V(A) in percent.

CONCLUSIONS/INTERPRETATION: In children with type 1 diabetes, the diffusing capacity diminishes early in childhood and is associated with poor metabolic control. Although low DL(CO)/V(A) levels in these children probably reflect pulmonary microangiopathy induced by type 1 diabetes, other factors presumably influencing CO diffusion capacity measurements (e.g. a left shift in HbA(1)c resulting in high O(2) binding and low CO binding) could explain the apparent capillary and alveolar basal membrane dysfunction.

摘要

目的/假设:关于糖尿病患儿肺功能障碍的数据较少。我们研究了1型糖尿病患儿的肺功能变量(流量、容积和肺泡毛细血管弥散)与疾病相关变量之间的关联。

方法

我们研究了39例1型糖尿病患儿(平均年龄10.9±2.6岁,病程3.6±2.4年,胰岛素用量0.77±0.31U·kg⁻¹·d⁻¹)和30例健康对照儿童(平均年龄10.4±3.0岁)。肺功能测试包括肺活量测定、氮洗脱和根据肺泡容积校正的单次呼吸一氧化碳弥散量(DL(CO)/V(A))。根据糖化血红蛋白(HbA(1)c)评估血糖控制情况,HbA(1)c值≤8%被认为血糖控制良好,HbA(1)c值>8%被认为血糖控制不佳。

结果

血糖控制不佳的患儿预测流量和容积的百分比值与血糖控制良好的患儿及健康对照儿童相当,但DL(CO)/V(A)值低于他们(86.7±12.6 vs 99.8±18.4和102.0±15.7;p<0.05)。预测的DL(CO)/V(A)百分比与HbA(1)c水平相关(r=-0.39,p=0.013)。一项控制HbA(1)c水平和其他疾病相关变量(发病年龄、病程、每日胰岛素剂量/kg、性别)的多元回归分析(逐步模型)确定HbA(1)c水平是DL(CO)/V(A)百分比的唯一预测因素。

结论/解读:在1型糖尿病患儿中,弥散能力在儿童早期就会降低,且与代谢控制不佳有关。尽管这些患儿较低的DL(CO)/V(A)水平可能反映了1型糖尿病所致的肺微血管病变,但其他可能影响一氧化碳弥散能力测量的因素(如HbA(1)c左移导致氧结合增加和一氧化碳结合减少)也可能解释明显的毛细血管和肺泡基底膜功能障碍。

相似文献

1
Diffusing capacity for carbon monoxide in children with type 1 diabetes.1型糖尿病患儿的一氧化碳弥散能力
Diabetologia. 2004 Nov;47(11):1931-5. doi: 10.1007/s00125-004-1548-7. Epub 2004 Nov 24.
2
Diabetes mellitus and lung function.糖尿病与肺功能。
Med Princ Pract. 2003 Apr-Jun;12(2):87-91. doi: 10.1159/000069118.
3
Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy.2型糖尿病患者肺泡微血管储备减少反映了全身性微血管病变。
Diabetes Care. 2008 Aug;31(8):1596-601. doi: 10.2337/dc07-2323. Epub 2008 May 20.
4
A rebreathing method to determine carbon monoxide diffusing capacity in children: reference values for 6- to 18-year-olds [corrected] and validation in adult volunteers.一种用于测定儿童一氧化碳弥散能力的重复呼吸法:6至18岁儿童的参考值[校正后]及在成年志愿者中的验证
Pediatr Pulmonol. 1998 Mar;25(3):205-12. doi: 10.1002/(sici)1099-0496(199803)25:3<205::aid-ppul11>3.0.co;2-a.
5
The single-breath diffusing capacity of CO and NO in healthy children of European descent.欧洲裔健康儿童中一氧化碳和一氧化氮的单次呼吸弥散能力。
PLoS One. 2014 Dec 16;9(12):e113177. doi: 10.1371/journal.pone.0113177. eCollection 2014.
6
Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy.
Nephron. 1996;74(2):395-400. doi: 10.1159/000189342.
7
Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者肺弥散能力的体位变化
Chest. 1996 Oct;110(4):1009-13. doi: 10.1378/chest.110.4.1009.
8
Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.1 型糖尿病患者起始持续皮下胰岛素输注治疗的血糖控制预测因素。
Diabet Med. 2010 Mar;27(3):339-47. doi: 10.1111/j.1464-5491.2009.02925.x.
9
Pulmonary diffusing capacity at reduced alveolar volumes in children.儿童肺泡容积降低时的肺弥散能力
Pediatr Pulmonol. 1996 Feb;21(2):84-9. doi: 10.1002/(SICI)1099-0496(199602)21:2<84::AID-PPUL4>3.0.CO;2-P.
10
Pulmonary diffusing capacity in healthy Caucasian children.健康白种儿童的肺弥散量。
Pediatr Pulmonol. 2012 May;47(5):469-75. doi: 10.1002/ppul.21564. Epub 2011 Nov 11.

引用本文的文献

1
The association between OSA and glycemic control in diabetes.阻塞性睡眠呼吸暂停(OSA)与糖尿病患者血糖控制之间的关联。
Int J Prev Med. 2023 Feb 25;14:26. doi: 10.4103/ijpvm.ijpvm_356_21. eCollection 2023.
2
The Diabetic Lung: Insights into Pulmonary Changes in Children and Adolescents with Type 1 Diabetes.糖尿病性肺脏:对1型糖尿病儿童和青少年肺部变化的见解
Metabolites. 2021 Jan 26;11(2):69. doi: 10.3390/metabo11020069.
3
Pulmonary vascular dysfunction in metabolic syndrome.代谢综合征中的肺血管功能障碍。

本文引用的文献

1
Lung function abnormalities in children with type I diabetes.
Respir Med. 2002 Dec;96(12):976-8. doi: 10.1053/rmed.2002.1402.
2
Pulmonary diffusing capacity, serum angiotensin-converting enzyme activity and the angiotensin-converting enzyme gene in Japanese non-insulin-dependent diabetes mellitus patients.日本非胰岛素依赖型糖尿病患者的肺弥散能力、血清血管紧张素转换酶活性及血管紧张素转换酶基因
Diabetes Res Clin Pract. 1999 Mar;43(3):173-7. doi: 10.1016/s0168-8227(99)00006-6.
3
Diabetes mellitus induces a thickening of the pulmonary basal lamina.糖尿病会导致肺基底膜增厚。
J Physiol. 2019 Feb;597(4):1121-1141. doi: 10.1113/JP275856. Epub 2018 Sep 12.
4
Type 1 Diabetes Duration Decreases Pulmonary Diffusing Capacity during Exercise.1型糖尿病病程会降低运动期间的肺弥散能力。
Respiration. 2016;91(2):164-70. doi: 10.1159/000443181. Epub 2016 Jan 13.
5
Evaluation of pulmonary function changes in children with type 1 diabetes mellitus in Upper Egypt.埃及上埃及地区1型糖尿病患儿肺功能变化的评估
Ther Adv Endocrinol Metab. 2015 Jun;6(3):87-91. doi: 10.1177/2042018815580514.
6
Alterations in lung gene expression in streptozotocin-induced diabetic rats.链脲佐菌素诱导糖尿病大鼠肺组织基因表达的改变。
BMC Endocr Disord. 2014 Jan 15;14:5. doi: 10.1186/1472-6823-14-5.
7
Noninvasive measurement of plasma glucose from exhaled breath in healthy and type 1 diabetic subjects.健康人和 1 型糖尿病患者呼出气中血浆葡萄糖的无创测量。
Am J Physiol Endocrinol Metab. 2011 Jun;300(6):E1166-75. doi: 10.1152/ajpendo.00634.2010. Epub 2011 Apr 5.
8
Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes.血糖控制影响 1 型糖尿病运动训练受试者的肺膜弥散和氧饱和度:1 型糖尿病的肺泡毛细血管膜导度。
Eur J Appl Physiol. 2011 Mar;111(3):567-78. doi: 10.1007/s00421-010-1663-8. Epub 2010 Oct 10.
Respiration. 1999;66(1):14-9. doi: 10.1159/000029331.
4
Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus.
Am J Med. 1997 Dec;103(6):504-13. doi: 10.1016/s0002-9343(97)00251-9.
5
Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop.人体肺容积的测量:美国胸科学会/欧洲呼吸学会研讨会的综述与建议
Eur Respir J. 1997 Jun;10(6):1205-6. doi: 10.1183/09031936.97.10061205.
6
Postural variations of pulmonary diffusing capacity in insulin-dependent diabetes mellitus.胰岛素依赖型糖尿病患者肺弥散能力的体位变化
Chest. 1996 Oct;110(4):1009-13. doi: 10.1378/chest.110.4.1009.
7
American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update.美国胸科学会。单次呼吸一氧化碳弥散量(转移因子)。标准技术建议——1995年更新版。
Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2185-98. doi: 10.1164/ajrccm.152.6.8520796.
8
Pulmonary function in diabetic children with and without persistent microalbuminuria.有和无持续性微量白蛋白尿的糖尿病儿童的肺功能
Diabetes Res Clin Pract. 1993 Aug-Sep;21(2-3):171-6. doi: 10.1016/0168-8227(93)90066-e.
9
Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus.
Diabetes Res Clin Pract. 1994 Oct;25(3):161-8. doi: 10.1016/0168-8227(94)90004-3.
10
Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease.儿童糖尿病患者关节活动受限表明微血管疾病风险增加。
N Engl J Med. 1981 Jul 23;305(4):191-4. doi: 10.1056/NEJM198107233050403.